Last reviewed · How we verify
NCT03699722: Just4Us
A Women-Focused PrEP Intervention
Phase 1 trial testing Education + Activities in Behavior and Behavior Mechanisms in 83 participants. Completed in 10 November 2019.
10 October 2019
Quick facts
| Lead sponsor | University of Pennsylvania |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 83 |
| Start date | 3 November 2018 |
| Primary completion | 10 October 2019 |
| Estimated completion | 10 November 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Education + Activities
- Information
Conditions studied
- Behavior and Behavior Mechanisms — all drugs for Behavior and Behavior Mechanisms →
- Information Literacy — all drugs for Information Literacy →
Sponsor
University of Pennsylvania
Who can join
Adults 18 to 55, female only, with Behavior and Behavior Mechanisms or Information Literacy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many women at high risk for acquiring HIV infection are not aware of preexposure prophylaxis (PrEP), an efficacious, self-administered, woman-controlled, HIV prevention product. The objective of this study is to evaluate the feasibility and acceptability of a theory-based intervention to promote PrEP uptake and adherence in a pilot trial among 80 women. The study will also measure intention to use PrEP and actual initiation of PrEP use. The investigators hypothesize that the intervention will be acceptable and feasible and that the intervention group will report higher levels of PrEP uptake, intention to use and adhere to PrEP, and other variables regarding PrEP uptake, comparing baseline, post-intervention and 3 month follow-up assessments.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Just4Us: Development of a Counselor-Navigator and Text Message Intervention to Promote PrEP Uptake Among Cisgender Women at Elevated Risk for HIV.
Teitelman AM, Koblin BA, Brawner BM, Davis A, et al · · 2021 · cited 14× · PMID 33427767 · DOI 10.1097/jnc.0000000000000233 -
A Randomized Controlled Pilot Study of Just4Us, a Counseling and Navigation Intervention to Promote Oral HIV Prophylaxis Uptake Among PrEP-Eligible Cisgender Women.
Teitelman AM, Tieu HV, Chittamuru D, Shaw PA, et al · · 2023 · cited 6× · PMID 36869921 · DOI 10.1007/s10461-023-04017-z -
A Randomized Controlled Pilot Study of Just4Us, a Counseling and Navigation Intervention to Promote Oral HIV Prophylaxis Uptake Among PrEP-Eligible Cisgender Women
Teitelman A, Tieu H, Chittamuru D, Shaw PA, et al · · 2022 · DOI 10.21203/rs.3.rs-2322407/v1
Verify or expand the search:
- PubMed search for NCT03699722
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Behavior and Behavior Mechanisms
Currently open trials in the same condition.
- NCT06810570 — The Effect of Mobile Devices on the Development and Health of Young Children · recruiting
- NCT06337500 — Validation of a Making Decision Hybrid (Ecologic and Virtual) Task · NA · recruiting
- NCT06146348 — Deimplementing CXR After CVC (DRAUP) in the ICU · NA · recruiting
- NCT06322966 — Learning and Living With Wildfire Smoke · NA · active not recruiting
- NCT05201534 — Interventions in Mathematics and Cognitive Skills · NA · recruiting
Other University of Pennsylvania trials
Trials by the same sponsor.
- NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
- NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
- NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03699722 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
- Last refreshed: 13 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03699722.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing